Galapagos N.V. ( GLPG) - Key Metrics
Stock symbol GLPG is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker GLPG was renamed to
LKFT
effective 2026-05-08.
GLPG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $13.67 | $11.87 | -$0.64 | -$0.67 |
| 2025Q3 | $1.09 | -$3.10 | -$0.96 | -$1 |
| 2025Q2 | $0.99 | -$1.60 | -$1.65 | -$1.71 |
| 2025Q1 | $1.14 | -$2.33 | -$0.59 | -$0.67 |
| 2024Q4 | $0.86 | $0.29 | -$0.68 | -$0.74 |
GLPG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 0.59 |
| 2025Q3 | ? | -2.35 |
| 2025Q2 | ? | -3.70 |
| 2025Q1 | ? | -2.50 |
| 2024Q4 | ? | 22.94 |
GLPG
Price: $28.62
52 week price:
Earnings Per Share: -7.96 USD
P/E Ratio: -4.28
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Belgium
Volume: 69406
Ebitda: -23.5 millionMarket Capitalization: 1.9 billion